首页> 外文期刊>Journal of Inclusion Phenomena and Macrocyclic Chemistry >A double-blind placebo-controlled study of 5-fluorouracil:cyclodextrin complex loaded thermosensitive gel for the treatment of HPV induced condyloma
【24h】

A double-blind placebo-controlled study of 5-fluorouracil:cyclodextrin complex loaded thermosensitive gel for the treatment of HPV induced condyloma

机译:装有5-氟尿嘧啶:环糊精复合物的热敏凝胶的双盲安慰剂对照研究,用于治疗HPV诱发的尖锐湿疣

获取原文
获取原文并翻译 | 示例
           

摘要

Objective of this double-blind placebo-controlled study was to determine the efficacy of thermosensitive mucoadhesive gel loaded with 5-fluorouracil (5-FU): hydroxypropyl-8-cyclodextrin (HP-B-CD) complex via topical administration or intralesional injection for the treatment of human papilloma virus induced condyloma in 44 women. The diagnosis of human papilloma virus was established with clinical, histopathological and polymerase chain reaction techniques. Subjects were randomized into four parallel groups to evaluate topical or intralesional administration of drug-loaded or blank gel. The formulation used in the study consisted of 20% Pluronic PF 127 and 0.2% hydroxypropylmethylcellulose (HPMC) to render thermosensitive and mucoadhesive properties to the blank and drug-loaded gels. 5-FU was complexed to hydroxy-propyl-6-cyclodextrin to improve its solubility and this complex was loaded into thermosensitive gel to obtain controlled release of the cytotoxic drug in administration site over a two-week period cure regimen aiming therapeutic efficacy with lower 5-FU doses. Complete response was achieved in 61% of patients through intralesional administration while topical administration resulted in only 29% complete cure. Relapse rates of all therapy groups were significantly low in the 6-month follow-up time.
机译:这项双盲安慰剂对照研究的目的是通过局部给药或病灶内注射确定5-氟尿嘧啶(5-FU):羟丙基-8-环糊精(HP-B-CD)复​​合物负载的热敏粘膜粘附胶的功效。治疗人乳头瘤病毒诱发的尖锐湿疣44例人乳头瘤病毒的诊断是通过临床,组织病理学和聚合酶链反应技术建立的。将受试者随机分为四个平行组,以评估局部或病灶内载药或空白凝胶的给药。研究中使用的配方由20%的Pluronic PF 127和0.2%的羟丙基甲基纤维素(HPMC)组成,可对空白和载有药物的凝胶提供热敏和粘膜粘附特性​​。将5-FU与羟丙基-6-环糊精复合以提高其溶解度,并将该复合物加载到热敏凝胶中,以期在两周的治疗方案中在治疗部位控制释放细胞毒性药物,目标是降低5 -FU剂量。通过病灶内给药在61%的患者中获得了完全缓解,而局部给药仅使29%的患者完全治愈。在六个月的随访时间内,所有治疗组的复发率均显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号